Cargando…

Association of rs3750920 polymorphism in TOLLIP with clinical characteristics of fibrosing interstitial lung diseases in Japanese

TOLLIP polymorphism has been implicated in the development and prognosis of idiopathic pulmonary fibrosis (IPF), mainly in whites. However, ethnic differences in the characteristics of other interstitial pneumonia (non-IPF) subtypes are unclear. We evaluated the association between the rs3750920 gen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Isshiki, Takuma, Koyama, Kazuya, Homma, Sakae, Sakamoto, Susumu, Yamasaki, Akira, Shimizu, Hiroshige, Miyoshi, Shion, Nakamura, Yasuhiko, Kishi, Kazuma
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8355271/ https://www.ncbi.nlm.nih.gov/pubmed/34376770 http://dx.doi.org/10.1038/s41598-021-95869-9

Ejemplares similares

Serum autotaxin levels in chronic disease and acute exacerbation of fibrosing interstitial lung disease
por: Isshiki, Takuma, et al.
Publicado: (2022)

Outcomes and prognosis of progressive pulmonary fibrosis in patients with antineutrophil cytoplasmic antibody-positive interstitial lung disease
por: Sakamoto, Susumu, et al.
Publicado: (2023)

Association of serum high-mobility group box protein 1 level with outcomes of acute exacerbation of idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia
por: Shimizu, Hiroshige, et al.
Publicado: (2018)

Association of serum monomeric periostin level with outcomes of acute exacerbation of idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia
por: Shimizu, Hiroshige, et al.
Publicado: (2021)

The Activities of Daily Living after an Acute Exacerbation of Idiopathic Pulmonary Fibrosis
por: Koyama, Kazuya, et al.
Publicado: (2017)

Immunohistochemical Detection of Propionibacterium acnes in Granulomas for Differentiating Sarcoidosis from Other Granulomatous Diseases Utilizing an Automated System with a Commercially Available PAB Antibody
por: Isshiki, Takuma, et al.
Publicado: (2021)

Therapeutic Role of Recombinant Human Soluble Thrombomodulin for Acute Exacerbation of Idiopathic Pulmonary Fibrosis
por: Isshiki, Takuma, et al.
Publicado: (2019)

New risk scoring system for predicting 3-month mortality after acute exacerbation of idiopathic pulmonary fibrosis
por: Sakamoto, Susumu, et al.
Publicado: (2022)

Role of imaging in progressive-fibrosing interstitial lung diseases
por: Walsh, Simon L.F., et al.
Publicado: (2018)

Tollip or Not Tollip: What Are the Evolving Questions behind It?
por: Luiz, Denis Prudencio, et al.
Publicado: (2014)

Clinical importance of long non-coding RNA LINC00460 expression in EGFR-mutant lung adenocarcinoma
por: Nakano, Yuta, et al.
Publicado: (2019)

Impact of accurate diagnosis of interstitial lung diseases on postoperative outcomes in lung cancer
por: Azuma, Yoko, et al.
Publicado: (2022)

Treatment with antifibrotic agents in idiopathic pleuroparenchymal fibroelastosis with usual interstitial pneumonia
por: Sugino, Keishi, et al.
Publicado: (2021)

Successful Use of Pembrolizumab to Treat Refractory Thymic Carcinoma with High PD-L1 Expression
por: Isshiki, Takuma, et al.
Publicado: (2018)

Exophiala dermatitidis pneumonia with bronchiectasis required prolonged voriconazole treatment
por: Sekiguchi, Ryo, et al.
Publicado: (2021)

Development of Propionibacterium acnes-associated Sarcoidosis During Etanercept Therapy
por: Isshiki, Takuma, et al.
Publicado: (2019)

Elective lung resection after treatment for COVID-19 pneumonia
por: Sakai, Takashi, et al.
Publicado: (2021)

Progression of fibrosing interstitial lung disease
por: Wong, Alyson W., et al.
Publicado: (2020)

Management of Fibrosing Interstitial Lung Diseases
por: Maher, Toby M., et al.
Publicado: (2019)

Benefits of Pulmonary Rehabilitation in Patients with Idiopathic Pulmonary Fibrosis Receiving Antifibrotic Drug Treatment
por: Iwanami, Yuji, et al.
Publicado: (2022)

Fatal Invasive Pulmonary Aspergillosis Associated with Nonspecific Interstitial Pneumonia: An Autopsy Case Report
por: Matsuyama, Hisayo, et al.
Publicado: (2018)

The Burden of Progressive-Fibrosing Interstitial Lung Diseases
por: Cottin, Vincent, et al.
Publicado: (2022)

Management of patients with fibrosing interstitial lung diseases
por: Morrow, Lee E, et al.
Publicado: (2021)

Fibrosing interstitial lung diseases: knowns and unknowns
por: Cottin, Vincent, et al.
Publicado: (2019)

Tollip Is a Mediator of Protein Sumoylation
por: Ciarrocchi, Alessia, et al.
Publicado: (2009)

Efficacy of three sputum specimens for the diagnosis of Mycobacterium avium complex pulmonary disease
por: Urabe, Naohisa, et al.
Publicado: (2023)

Activation of mucosal-associated invariant T cells in the lungs of sarcoidosis patients
por: Matsuyama, Hisayo, et al.
Publicado: (2019)

Biomarkers of Fibroproliferative Healing in Fibrosing Idiopathic Interstitial Pneumonias
por: Vasakova, Martina, et al.
Publicado: (2012)

The natural history of progressive fibrosing interstitial lung diseases
por: Kolb, Martin, et al.
Publicado: (2019)

The natural history of progressive fibrosing interstitial lung diseases
por: Brown, Kevin K., et al.
Publicado: (2020)

Management and support of patients with fibrosing interstitial lung diseases
por: Barbera, Tyonn, et al.
Publicado: (2021)

Predictors of Mortality in Progressive Fibrosing Interstitial Lung Diseases
por: Chen, Xianqiu, et al.
Publicado: (2021)

The Role of Radiology in Progressive Fibrosing Interstitial Lung Disease
por: Abu Qubo, Ahmad, et al.
Publicado: (2022)

Acute exacerbations of progressive-fibrosing interstitial lung diseases
por: Kolb, Martin, et al.
Publicado: (2018)

Nintedanib in children and adolescents with fibrosing interstitial lung diseases
por: Deterding, Robin, et al.
Publicado: (2023)

Burden of illness in progressive fibrosing interstitial lung disease
por: Singer, David, et al.
Publicado: (2022)

Pulmonary Hypertension in Patients with Chronic Fibrosing Idiopathic Interstitial Pneumonias
por: Hoeper, Marius M., et al.
Publicado: (2015)

Diffuse pulmonary ossification associated with fibrosing interstitial lung disease
por: Alami, Badreeddine, et al.
Publicado: (2019)

Potential of nintedanib in treatment of progressive fibrosing interstitial lung diseases
por: Wollin, Lutz, et al.
Publicado: (2019)

Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases
por: Cottin, Vincent, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_siurp0ghk3fc3mdhr7g1oht41h